- Report
- March 2026
- 135 Pages
Global
From €4486EUR$4,850USD£3,749GBP
- Report
- January 2026
- 190 Pages
Global
From €4578EUR$4,950USD£3,826GBP
- Report
- January 2026
- 97 Pages
Global
From €3191EUR$3,450USD£2,667GBP
- Report
- January 2026
- 187 Pages
Global
From €4301EUR$4,650USD£3,595GBP
- Report
- November 2025
Global
From €6937EUR$7,500USD£5,798GBP
- Report
- October 2025
- 85 Pages
Global
From €4162EUR$4,500USD£3,479GBP
- Report
- February 2026
- 150 Pages
United States
From €3699EUR$3,999USD£3,091GBP
- Report
- August 2026
- 70 Pages
Europe
From €4393EUR$4,750USD£3,672GBP
- Report
- August 2026
- 70 Pages
Asia Pacific
From €4393EUR$4,750USD£3,672GBP
- Report
- July 2026
- 70 Pages
Africa, Middle East
From €4393EUR$4,750USD£3,672GBP
- Report
- July 2026
- 80 Pages
Europe
From €4393EUR$4,750USD£3,672GBP
- Report
- July 2026
- 150 Pages
North America
From €4393EUR$4,750USD£3,672GBP
- Report
- March 2026
- 150 Pages
United States
From €4486EUR$4,850USD£3,749GBP
- Report
- November 2025
- 111 Pages
Europe
From €3006EUR$3,250USD£2,512GBP
- Report
- November 2025
- 101 Pages
Asia Pacific
From €3006EUR$3,250USD£2,512GBP
- Report
- November 2025
- 60 Pages
United States
From €2358EUR$2,550USD£1,971GBP
- Report
- November 2025
- 60 Pages
United States
From €2358EUR$2,550USD£1,971GBP
- Report
- November 2025
- 110 Pages
North America
From €3006EUR$3,250USD£2,512GBP
- Report
- November 2025
- 140 Pages
Europe
From €3006EUR$3,250USD£2,512GBP
- Report
- February 2026
- 109 Pages
North America
From €5545EUR$5,995USD£4,634GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more